1. Home
  2. FRSX vs VTAK Comparison

FRSX vs VTAK Comparison

Compare FRSX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$2.39

Market Cap

4.0M

Sector

Technology

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.37

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
VTAK
Founded
N/A
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
2.9M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
FRSX
VTAK
Price
$2.39
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.8K
784.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.53
EPS
N/A
N/A
Revenue
N/A
$442,000.00
Revenue This Year
N/A
$822.86
Revenue Next Year
N/A
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3057.14
52 Week Low
$0.31
$0.15
52 Week High
$3.00
$4.31

Technical Indicators

Market Signals
Indicator
FRSX
VTAK
Relative Strength Index (RSI) 60.70 40.09
Support Level $2.05 $1.14
Resistance Level $2.49 $2.05
Average True Range (ATR) 0.20 0.13
MACD 0.04 0.00
Stochastic Oscillator 72.13 4.93

Price Performance

Historical Comparison
FRSX
VTAK

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: